New Cannabis Products: Lil Wayne's New Strain, Wayne Coyne's Brand, A Non-Alcoholic Spirit – Yahoo Finance
As the cannabis market expands, it's not easy to keep track of the many products launching every week. But don’t worry, Benzinga always keeps you updated on the most interesting new cannabis products being launched.
Mr. Carter OG
GKUA, the cannabis brand founded by Lil Wayne, released a limited “sneak preview” of its new exclusive flower strain, Mr. Carter OG, in select California dispensaries. A larger, widespread release across California is scheduled for May.
The Mr. Carter OG strain was developed in partnership with 3C Farms, a heralded LA-based cultivator that has been in the game for two decades.
Love Yer Brain
Flaming Lips’ frontman, Wayne Coyne, launched his own cannabis brand, Love Yer Brain, which debuted in his home state of Oklahoma and released in partnership with Sands Lane Ventures and Ojos Del Mundo.
With a focus on inspiring creativity, the Flaming Lips aligns with Coyne’s persona and his love of art and music. The first product line for Love Yer Brain features brain-shaped gummies, available in three flavors (watermelon, green apple, raspberry) and two potencies (10mg and 25mg per gummy).
“Being authentic is key to having a successful cannabis brand, and I can’t think of a better person to be aligned with than Wayne Coyne, who has been instrumental in promoting creativity throughout his life in his music and art,” Sands Lane Ventures founder Evan Eneman told Benzinga.
Pamos
Pamos is a non-alcoholic cannabis spirit crafted from natural ingredients. It's also low in sugar and light on THC and CBD.
Available in a 750ml bottle (enough for roughly 16 servings), Pamos is crafted in California with locally sourced ingredients. The drink comes in two strengths: the "Micro Dose," which features 2mg of THC and 2mg of CBD per serving and costs $60 and the "Low Dose," which features 6mg of THC and 2mg of CBD per serving and costs $65.
Pamos is infused with citrus, sweet fruit and aromatic herbs and spices.
"Our vision at Pamos is to use our product line to break down barriers and remove any stigma that consumers may associate with cannabis consumption. We firmly believe that beverages that mimic the ritual and form of a traditional cocktail will help broaden the consumer set and provide the canna-curious consumer with an easy entry point into cannabis,” David Mukpo, Pamos’ CEO and co-founder, told Benzinga. “Our commitment is to meet the growth in the beverage segment with premium quality products that fit into mainstream consumption habits and address consumer focus on health and wellness. By combining cocktail form and cannabis function, Pamos provides people a way to enjoy the moment without any regrets."
Encuentra nuestro contenido en Español en El Planteo:
Mascotas y Marihuana: Hablamos con Cannvet, Agrupación Veterinaria Orientada al Cannabis Medicinal
¿Se Puede Tener una Sobredosis de Marihuana?
Puerto Rico Entra de Lleno a la Revolución Del Cáñamo con PR Hemp Biz
Courtesy images.
See more from Benzinga
Click here for options trades from Benzinga
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
TechforCann, Europe's Cannabis Tech Accelerator, Raises Million
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The memory giant rose on reports that China may be throwing in the towel on subsidizing competitors.
Buffett's company, Berkshire Hathaway, is much more invested in the tech sector than it used to be.
Semiconductor investors got some good news Wednesday morning, when Bloomberg reported that an expected surge in Chinese support for its domestic semiconductor industry may not be as big a threat as was once supposed. As of 11:35 a.m. ET, Intel (NASDAQ: INTC) is up 4.3%, Qualcomm (NASDAQ: QCOM) is gaining 4%, and Taiwan Semiconductor Manufacturing (NYSE: TSM) is tacking on 2.6%. Just a few weeks ago, semiconductor investors got spooked by a December plan by China's government to shower $143 billion in subsidies upon its domestic semiconductor companies — nearly twice the level of support promised to U.S. semiconductor companies by the Biden administration.
It's the second trading day of the new year, and with the Nasdaq Composite index rising more than 1% in early afternoon trading, it looks like things are off to a good start for tech stocks. Microsoft (NASDAQ: MSFT) however, is missing out on the rally. Bright and early Wednesday morning, UBS analyst Karl Keirstead downgraded Microsoft stock from buy to neutral — and cut the bank's price target on the tech company by 17% for good measure, says StreetInsider.com.
Yahoo Finance Live anchors discuss GE HealthCare completing its spin-off from General Electric.
The On-Balance-Volume (OBV) line shows some slight improvement from late September. The Moving Average Convergence Divergence (MACD) oscillator is bullish. The weekly OBV line has stayed steady but the MACD oscillator is now above the zero line and bullish.
The Nasdaq Composite (NASDAQINDEX: ^IXIC) tried to bounce back on Wednesday morning, seeking to recover losses from the first trading day of 2023. As of shortly after the opening bell, the Nasdaq had moved up by more than half a percent. Individual stocks within the Nasdaq have seen huge swings, and even the largest companies haven't been immune from big ups and downs.
Yahoo Finance Live breaks down analyst concerns in Microsoft's Azure cloud unit, also commenting on the tech company's partnership with ChatGPT.
The current rate is good, but if you hold off until just before the next change, it could be even better.
Rivian stock had recently dropped to an all-time low price, so reduced investor expectations for fourth-quarter and full-year deliveries were already built in. At that valuation, the investment thesis relies on strong and continued growth in production volume.
Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road.
A kidney disease treatment from Vera lagged rivals from Chinook and Otsuka, analysts said Wednesday as the biotech stock plummeted.
The über-rich are keeping their powder dry in the new year, a poll of ultra-high-net-worth investors found. Then they'll "pounce."
S&P Global Ratings Senior Director and Sector Lead for Autos, Business, and Technology Services Nishit Madlani joins Yahoo Finance Live to discuss Tesla’s credit grade, the EV maker’s ability to hit production targets, and the outlook for the stock.
Yahoo Finance's Seana Smith breaks down how stocks are moving in afternoon trading.
For Citi customers with a sizable sum on hand, opening a new savings account can deliver just that — but, of course, not without significant hurdles. Like many bank accounts these days, the Citi® Savings Account comes with the promise of a hefty sign-up bonus — up to $3,500 — for simply opening a new account and “completing required activities.” Chanelle Bessette, banking specialist at NerdWallet, says offerings like these, albeit eye-catching at first glance, show just why it’s critical to read the fine print.
In December, shopping was on the agenda for a lot of us, including superstar investor Cathie Wood. Speaking of other programs, CRISPR recently reported positive data from a phase 1 trial of an immuno-oncology candidate.
Another sell-off lurks in Tesla's stock, warns one veteran analyst.
Yahoo Finance’s Jared Blikre reports on how stocks are trading ahead of the closing bell.
Companies in The News Are: LIN, WYNN, NVDA, DVN
